ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,589, issued on April 14, was assigned to NIPPON SHINYAKU Co. LTD. (Kyoto, Japan).
"Prophylactic and/or therapeutic agent for chronic prostatitis/chronic pelvic pain syndrome" was invented by Ken Okamoto (Kyoto, Japan), Maki Kurita (Kyoto, Japan) and Hiroshi Yamaguchi (Kyoto, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a prophylactic and/or therapeutic agent for chronic prostatitis/chronic pelvic pain syndrome, the agent containing an mPGES-1 inhibitor as an active ingredient."
The patent was filed on Dec. 24, 2020, under Application No. 17/788,516.
*For further information, including images, charts and ta...